Header Logo

Connection

Gary Raskob to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Gary Raskob has written about Clinical Trials, Phase III as Topic.
Gary Raskob
Connection Strength
0.027
Clinical Trials, Phase III as Topic
  1. Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups. J Thromb Haemost. 2013 Mar; 11(3):444-51.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.